ImpediMed Limited Q3 2023 Quarterly Investor Presentation

ImpediMed reports continued momentum with private payors on reimbursement policies, with approximately 85% expected to publish positive coverage policies by June 2024. The company demonstrates strong SaaS metrics and measured cost control aligned with payor timelines, positioning itself as a first-mover with no direct competition in its market segment.